首页> 美国卫生研究院文献>Healthcare >Role of Laboratory Medicine in SARS-CoV-2 Diagnostics. Lessons Learned from a Pandemic
【2h】

Role of Laboratory Medicine in SARS-CoV-2 Diagnostics. Lessons Learned from a Pandemic

机译:实验室医学在SARS-COV-2诊断中的作用。从大流行中吸取的经验教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since the 2019 novel coronavirus outbreak began in Wuhan, China, diagnostic methods in the field of molecular biology have been developing faster than ever under the vigilant eye of world’s research community. Unfortunately, the medical community was not prepared for testing such large volumes or ranges of biological materials, whether blood samples for antibody immunological testing, or salivary/swab samples for real-time PCR. For this reason, many medical diagnostic laboratories have made the switch to working in the field of molecular biology, and research undertaken to speed up the flow of samples through laboratory. The aim of this narrative review is to evaluate the current literature on laboratory techniques for the diagnosis of SARS-CoV-2 infection available on pubmed.gov, Google Scholar, and according to the writers’ knowledge and experience of the laboratory medicine. It assesses the available information in the field of molecular biology by comparing real-time PCR, LAMP technique, RNA sequencing, and immunological diagnostics, and examines the newest techniques along with their limitations for use in SARS-CoV-2 diagnostics.
机译:自2019年新型冠状病毒爆发以来,中国武汉爆发以来,分子生物学领域的诊断方法一直在世界研究界的警惕的眼睛下发展。不幸的是,医学界没有准备测试这种大量或生物材料的范围,无论是抗体免疫检测的血液样本,还是实时PCR的唾液/拭子样品。因此,许多医学诊断实验室已经使开关在分子生物学领域工作,并通过实验室加快样品的流动。这种叙事审查的目的是评估目前关于诊断SARS-COV-2感染的实验室技术的文献,谷歌学者,谷歌学者,并根据作者的知识和实验室医学经验。它通过比较实时PCR,灯技术,RNA测序和免疫诊断,评估分子生物学领域的可用信息,并检查最新技术以及它们在SARS-COV-2诊断中使用的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号